Refractory/Relapse Acute Myeloid Leukemia
3 clinical trials · Condition
◉ Watch Refractory/Relapse Acute Myeloid Leukemia
| Record | Firm | Date |
|---|---|---|
| Allogeneic CAR-T(CT0890B) in NKG2DL+ R/R AML (NCT07617285) | Peking University People's Hospital | 2026-05-07 |
| Study of C6 Ceramide NanoLiposome (CNL) in Patients With Relapsed/Refractory Acute Myeloid Leukemia (NCT04716452) | Keystone Nano, Inc | 2025-10-01 |
| Venetoclax Combined With Azacitidine and CAG in Refractory/Relapse Acute Myeloid Leukemia (NCT05807347) | Hematology department of the 920th hospital | 2023-02-01 |
Track Refractory/Relapse Acute Myeloid Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.